Kapa Biosystems, Inc.

We are committed to answer our client's questions quickly and accurately. Currently, we are developing next-generation medicines for people suffering from cancer, chronic and rare diseases worldwide. We provide next-generation sequencing services on next-generation sequencing platforms (NGS), including proprietary technology platforms that offer quality data at unbeatable prices for a wide variety of sequencing services and clinical applications. All quality controls are built into our procedures at every step. Offering unrivaled flexibility in diagnostic testing, and affordable genomic sequencing. Our team of medical experts has developed reliable, comprehensive and actionable genetic tests, using next-generation sequencing of the genome and individual cells by using any of our 18000+ genes. Diploide is a leading provider of genomic services and solutions with next-generation NGS with the most extensive experience in bioinformatics, and the most advanced sequencing capability in the world. We offer a wide range of next-generation sequencing services with the world's largest portfolio of genetic testing panels, enhanced with the ability to develop algorithms, chips, specific and / or specialized arrangements for medical institutions, research institutions and other partners.

Through innovative clinicaland food safetynext-generation sequencing and software, we deliver clarityin infectious disease genome surveillance that can help protect human lives. Increase lab tech efficiency and productivity with our comprehensive and user-friendly next-generation sequencing platform.

We develop high fidelity polymerases used for Next Generation Sequencing pipelines and custom made kits in our own production facility. We are available to give advice at any stage of your project and we can assist you in finding a suitable sequencing solution. Our mission is to be Austria’s most comprehensive supplier of NextGen services, offering a range of speeds and outputs. Procomcure NGS is a division of Procomcure Biotech. Whole exome sequencing (WES) is a powerful tool for the investigation of genetic variance across the protein coding regions of the human genome. WES provides high confidence in variant calls for the identification of inherited rare Mendelian disorders, complex diseases and somatic mutations in cancer. Procomcure Biotech offers Human WES service for accurate variant detection using the Illumina NovaSeq 6000 and Dragen Bio-IT platforms. Procomcure Biotech offers WGS services for accurate variant detection using the Illumina NovaSeq 6000 and Dragen Bio-IT platforms.

Novogene uses leading technology from Illumina, Pacific Biosciences, Oxford Nanopore and Life Technologies, in our state-of-the-art sequencing centers in California (USA), Cambridge (UK), Singapore and China. Reliable and high quality NGS data is a key component in genomics research. At Novogene, we use the most effective technology available from world leading providers including Illumina NovaSeq 6000, HiSeq, Oxford Nanopore, Ion Torrent , PacBio Revio and PacBio Sequel platforms. Over the years our NGS labs have developed optimized NGS processes and protocols to ensure the best possible scientific outcome for your research. Not only do we offer state of the art NGS technology, we also have the largest sequencing capacity in the world with an annual throughput of over 280,000 human WGS samples.

Rather than one-medication-fits-all, precision medicine practitioners design specific disease treatments, management and prevention strategies based on high-resolution genetic and clinical data, such as genetic variations and imaging data. Genetic testing is pivotal in detecting and managing genetic disorders and diseases, there are four areas that are particularly useful. Next-Generation Sequencing (NGS) can be used to analyze DNA and RNA samples and holds many advantages over other microarray methods. Importantly, with NGS, an entire human genome can be sequenced within a single day; contrastingly, the previous Sanger sequencing technology required over a decade to deliver similar results. This means our clients, using NGS, can enjoy our genetic testing results at a much faster pace compared to alternative methods of genetic testing; as widely understood, time is crucial in the context of genetic diseases as the sooner a diagnosis, the sooner and more effective a treatment. Overall, NGS thus possesses better throughput, scalability, and speed than its respective counterparts, making its use a worthwhile decision and investment.

Your questions are our priority, and our analyses are purposefully designed to provide the insights essential to the success of your projects. At NextGenSeek, we empower scientific breakthroughs by providing state-of-the-art Next-Generation Sequencing (NGS) data analysis solutions. Driven by a passion for discovery, our mission is to accelerate genomics research by delivering thorough NGS data analysis services. We work with various sectors, including healthcare, biotechnology, pharmaceuticals, and academic research, offering tailored solutions to meet the unique challenges of each field. We offer extensive experience in analyzing NGS data across various platforms and experimental designs. Recognizing that each research project is unique, we offer customizable NGS data analysis solutions. Our streamlined workflows and efficient processes are designed to deliver results promptly, without compromising the quality of analysis. Embark on a journey of discovery with NextGenSeek, where cutting-edge technology meets unparalleled expertise in NGS data analysis.